--- title: "TerrAscend Corp. (TSNDF.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/TSNDF.US.md" symbol: "TSNDF.US" name: "TerrAscend Corp." industry: "制药" --- # TerrAscend Corp. (TSNDF.US) | Item | Detail | |------|--------| | Industry | 制药 | | Location | 美股市场 | | Website | [www.terrascend.com](https://www.terrascend.com) | ## Company Profile TerrAscend Corp.生产和销售医用大麻产品。该公司拥有多家企业和品牌,包括 The Apothecarium、Ilera Healthcare、Kind Tree、Prism、State Flower、Valhalla Confections 和 Arise Bioscience Inc. 该公司由 Basem Hanna、Vijay Sappani 和 Michael Nashat 于2017年3月7日创立,总部位于加拿大密西沙加。 ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-22T04:30:13.000Z **Overall: D (0.66)** **Industry**: Pharmaceuticals | Metric | Value | |--------|-------| | Industry Ranking | 144 / 190 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 3.91% | | | Net Profit YoY | -30.31% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.26 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 212.23M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 299.45M | | **Multi Score**: D #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -47.21% | E | | Profit Margin | -40.26% | E | | Gross Margin | 52.11% | B | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 3.91% | C | | Net Profit YoY | -30.31% | D | | Total Assets YoY | -15.48% | E | | Net Assets YoY | -53.90% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -248.38% | D | | OCF YoY | 3.91% | C | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.49 | C | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 82.80% | E | ```chart-data:radar { "title": "Longbridge Financial Score - TerrAscend Corp.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-47.21%", "rating": "E" }, { "name": "Profit Margin", "value": "-40.26%", "rating": "E" }, { "name": "Gross Margin", "value": "52.11%", "rating": "B" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "3.91%", "rating": "C" }, { "name": "Net Profit YoY", "value": "-30.31%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-15.48%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-53.90%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-248.38%", "rating": "D" }, { "name": "OCF YoY", "value": "3.91%", "rating": "C" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.49", "rating": "C" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "82.80%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 礼来 (US.LLY) | A | A | B | E | B | B | | 02 | ROCHE HOLDINGS AG (US.RHHVF) | A | B | B | D | C | B | | 03 | 罗氏(ADR) (US.RHHBY) | A | B | B | D | C | B | | 04 | 阿斯利康 (US.AZN) | A | B | C | D | C | B | | 05 | 诺华制药 (US.NVS) | A | B | C | D | C | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -1.76 | 128/257 | - | - | - | | PB | 2.26 | 98/257 | 2.70 | 1.87 | 0.75 | | PS (TTM) | 0.71 | 26/257 | 0.98 | 0.61 | 0.43 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-19T05:00:00.000Z Total Analysts: **3** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 3 | 100% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 0.57 | | Highest Target | 1.50 | | Lowest Target | 1.50 | ## References - [Company Overview](https://longbridge.com/en/quote/TSNDF.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/TSNDF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/TSNDF.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.